These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22999769)

  • 1. Factors influencing cervical cancer screening in women infected with HIV: a review of the literature.
    Chapman Lambert CL
    J Assoc Nurses AIDS Care; 2013; 24(3):189-97. PubMed ID: 22999769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Cervical Cancer Screening Techniques in HIV-Infected Women in Uganda.
    Bansil P; Lim J; Byamugisha J; Kumakech E; Nakisige C; Jeronimo JA
    J Low Genit Tract Dis; 2015 Jul; 19(3):215-9. PubMed ID: 25551591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cervical cancer.
    CA Cancer J Clin; 2020 Sep; 70(5):347-348. PubMed ID: 33460047
    [No Abstract]   [Full Text] [Related]  

  • 5. Pap test adherence, cervical cancer perceptions, and HPV knowledge among HIV-infected women in a community health setting.
    Lambert CC; Chandler R; McMillan S; Kromrey J; Johnson-Mallard V; Kurtyka D
    J Assoc Nurses AIDS Care; 2015; 26(3):271-80. PubMed ID: 25769754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cervical cancer: particularities in HIV patients].
    Grellier N; Quéro L
    Bull Cancer; 2014 Nov; 101(11):1040-7. PubMed ID: 25418597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
    Howell LP; Gurusinghe S; Tabnak F; Sciortino S
    Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.
    Hankins C; Coutlée F; Lapointe N; Simard P; Tran T; Samson J; Hum L
    CMAJ; 1999 Jan; 160(2):185-91. PubMed ID: 9951439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of cervical cancer screening and facing new problems in China].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
    [No Abstract]   [Full Text] [Related]  

  • 10. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The latest recommendations from the USPSTF.
    Campos-Outcalt D
    J Fam Pract; 2012 May; 61(5):278-82. PubMed ID: 22577630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer risk factors and predictors of cervical dysplasia among women in south-west Nigeria.
    Ogunbowale T; Lawoyin TO
    Aust J Rural Health; 2008 Dec; 16(6):338-42. PubMed ID: 19032205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HIV infection on atypical squamous cells of undetermined significance.
    Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
    Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
    Feticu L; Bocşan IS; Bondor Cl; Boboş C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervix dysplasia and cervix carcinoma].
    Bol P
    Ned Tijdschr Tandheelkd; 1998 Dec; 105(12):455-6. PubMed ID: 11928150
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding barriers for adherence to follow-up care for abnormal pap tests.
    Eggleston KS; Coker AL; Das IP; Cordray ST; Luchok KJ
    J Womens Health (Larchmt); 2007 Apr; 16(3):311-30. PubMed ID: 17439377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.